Literature DB >> 23809438

Roles of poly(ADP-ribose) glycohydrolase in DNA damage and apoptosis.

Xiaoxing Feng1, David W Koh.   

Abstract

Poly(ADP-ribose) glycohydrolase (PARG) is the primary enzyme that catalyzes the hydrolysis of poly(ADP-ribose) (PAR), an essential biopolymer that is synthesized by poly(ADP-ribose) polymerases (PARPs) in the cell. By regulating the hydrolytic arm of poly(ADP-ribosyl)ation, PARG participates in a number of biological processes, including the repair of DNA damage, chromatin dynamics, transcriptional regulation, and cell death. Collectively, the research investigating the roles of PARG in the cell has identified the importance of PARG and its value as a therapeutic target. However, the biological role of PARG remains less understood than the role of PAR synthesis by the PARPs. Further complicating the study of PARG is the existence of multiple PARG isoforms in the cell, the lack of optimal PARG inhibitors, and the lack of viable PARG-null animals. This review will present our current knowledge of PARG, with a focus on its roles in DNA-damage repair and cell death.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23809438     DOI: 10.1016/B978-0-12-407696-9.00005-1

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  23 in total

Review 1.  The rise and fall of poly(ADP-ribose): An enzymatic perspective.

Authors:  John M Pascal; Tom Ellenberger
Journal:  DNA Repair (Amst)       Date:  2015-05-01

Review 2.  PARkinson's: From cellular mechanisms to potential therapeutics.

Authors:  Zsofia Lengyel-Zhand; Laura N Puentes; Robert H Mach
Journal:  Pharmacol Ther       Date:  2021-08-12       Impact factor: 12.310

3.  Genomic variation reveals demographic history and biological adaptation of the ancient relictual, lotus (Nelumbo Adans).

Authors:  Xingwen Zheng; Tao Wang; Teng Cheng; Lingling Zhao; Xingfei Zheng; Fenglin Zhu; Chen Dong; Jinxing Xu; Keqiang Xie; Zhongli Hu; Liangbo Yang; Ying Diao
Journal:  Hortic Res       Date:  2022-02-19       Impact factor: 7.291

4.  Nutritional energy stimulates NAD+ production to promote tankyrase-mediated PARsylation in insulinoma cells.

Authors:  Linlin Zhong; Tsung-Yin J Yeh; Jun Hao; Nasim Pourtabatabaei; Sushil K Mahata; Jianhua Shao; Steven D Chessler; Nai-Wen Chi
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  PARG is dispensable for recovery from transient replicative stress but required to prevent detrimental accumulation of poly(ADP-ribose) upon prolonged replicative stress.

Authors:  Giuditta Illuzzi; Elise Fouquerel; Jean-Christophe Amé; Aurélia Noll; Kristina Rehmet; Heinz-Peter Nasheuer; Françoise Dantzer; Valérie Schreiber
Journal:  Nucleic Acids Res       Date:  2014-06-06       Impact factor: 16.971

6.  Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.

Authors:  Lianne E Rotin; Marcela Gronda; Neil MacLean; Rose Hurren; XiaoMing Wang; Feng-Hsu Lin; Jeff Wrana; Alessandro Datti; Dwayne L Barber; Mark D Minden; Malik Slassi; Aaron D Schimmer
Journal:  Oncotarget       Date:  2016-01-19

Review 7.  Metabolic modulation of chromatin: implications for DNA repair and genomic integrity.

Authors:  Jinping Liu; Jeongkyu Kim; Philipp Oberdoerffer
Journal:  Front Genet       Date:  2013-09-17       Impact factor: 4.599

Review 8.  Tankyrases: structure, function and therapeutic implications in cancer.

Authors:  Teemu Haikarainen; Stefan Krauss; Lari Lehtio
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 9.  The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy.

Authors:  M Li; X Yu
Journal:  Oncogene       Date:  2014-09-15       Impact factor: 9.867

10.  PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency.

Authors:  Aurélia Noll; Giuditta Illuzzi; Jean-Christophe Amé; Françoise Dantzer; Valérie Schreiber
Journal:  Cancer Cell Int       Date:  2016-07-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.